The Grand Roundup: Novo-Hims partnership, UHS buys Talkspace, OpenEvidence's "Spotify of healthcare" strategy & Wiley partnership, and Idaho Microhospitals

The episode covers a busy Monday in healthcare and markets: 

• Universal Health Services announced it will acquire Talkspace to expand outpatient behavioral health and virtual care, raising questions about Talkspace’s largely non‑W2 therapist model and the modest premium paid. 
• Hims and Hers and Novo Nordisk unexpectedly reengaged after a broken partnership and lawsuit, with Hims curtailing compounded GLP‑1 advertising, Novo dropping its lawsuit, and Novo products expected on the platform, boosting Hims’ stock. 
• Wiley’s AI-focused earnings call and partnership with OpenEvidence (including equity)
• CMS action against Elevance over risk-adjustment submissions via encrypted USB drives
• Hospital operators’ revenue growth driven mostly by price and coding intensity
• Idaho legislation targeting a freestanding ER’s heavy use of the No Surprises Act IDR process
• Private-market deals for FindHelp and Greater Good Health
• The collapse of New Mountain’s planned “Thoreau” spinout
• Operational and financing challenges of scaling cell and gene therapies.

For more from Health Tech Nerds, subscribe to our weekly newsletters: healthtechnerds.com/subscribe" target="_blank" rel="noopener noreferrer">https://www.healthtechnerds.com/subscribe